Publications

SCHEER - UPDATE of the GUIDELINES on the benefit-risk assessment of the presence of phthalates in certain medical devices covering phthalates which are carcinogenic, mutagenic, toxic to reproduction (CMR) or have endocrine-disrupting (ED) properties

Scientific specifications of medicinal products subject to joint clinical assessments

Guidance on outcomes for joint clinical assessments

Guidance on reporting requirements for multiplicity issues and subgroup, sensitivity and post hoc analyses in joint clinical assessments

Commission Decision (EU) 2024/1514

COM(2024) 214 final - Report from the Commission to the European Parliament and Council on delegated acts concerning biocidal products

SCCS Opinion on new coating for Titanium Dioxide (nano form)

Scientific Advice on Titanium dioxide (TiO2) (CAS/EC numbers 13463-67-7/236-675-5, 1317-70-0/215-280- 1, 1317-80-2/215-282-2)

Factsheet on European Health Data Space